ES461691A1 - Beta-lactam antibiotics - Google Patents

Beta-lactam antibiotics

Info

Publication number
ES461691A1
ES461691A1 ES461691A ES461691A ES461691A1 ES 461691 A1 ES461691 A1 ES 461691A1 ES 461691 A ES461691 A ES 461691A ES 461691 A ES461691 A ES 461691A ES 461691 A1 ES461691 A1 ES 461691A1
Authority
ES
Spain
Prior art keywords
beta
lactam antibiotics
gram
penicillins
lactamase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES461691A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES461691A1 publication Critical patent/ES461691A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5456Arylalkanephosphonium compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Salts of the compounds of the formula II are obtained by esterifying a salt of a corresponding 2-carboxylic acid. The products are antibacterially active and can increase the activity of penicillins and cephalosporins against ss-lactamase-producing strains of various Gram-positive and Gram-negative bacteria.
ES461691A 1976-08-17 1977-08-17 Beta-lactam antibiotics Expired ES461691A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB34106/76A GB1531141A (en) 1976-08-17 1976-08-17 Beta-lactam antibiotics

Publications (1)

Publication Number Publication Date
ES461691A1 true ES461691A1 (en) 1978-06-01

Family

ID=10361448

Family Applications (1)

Application Number Title Priority Date Filing Date
ES461691A Expired ES461691A1 (en) 1976-08-17 1977-08-17 Beta-lactam antibiotics

Country Status (19)

Country Link
JP (1) JPS5323995A (en)
AT (1) AT351678B (en)
AU (1) AU518375B2 (en)
BE (1) BE857781A (en)
CA (1) CA1104139A (en)
CH (1) CH639664A5 (en)
DE (1) DE2736482A1 (en)
DK (1) DK364177A (en)
ES (1) ES461691A1 (en)
FI (1) FI772432A (en)
FR (2) FR2362142A1 (en)
GB (1) GB1531141A (en)
IE (1) IE45559B1 (en)
IL (1) IL52638A (en)
NL (1) NL7709007A (en)
NZ (1) NZ184808A (en)
PT (1) PT66882B (en)
SE (1) SE7709071L (en)
ZA (1) ZA774703B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002564B1 (en) * 1977-11-12 1984-06-20 Beecham Group Plc Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates
EP0004132A1 (en) * 1978-03-04 1979-09-19 Beecham Group Plc Esters of beta-lactam antibiotics, a process for their preparation pharmaceutical compositions containing them and the compounds for use as antibacterial agents
US4446146A (en) * 1978-07-26 1984-05-01 Beecham Group Limited β-Lactam containing compounds, their preparation and use
EP0007753B1 (en) * 1978-08-02 1982-08-25 Beecham Group Plc Beta-lactam antibacterial agents, a process for their preparation and pharmaceutical compositions containing them
US4530791A (en) * 1979-04-16 1985-07-23 Kowa Co., Ltd. β-Lactam antibiotics
EP0024832B1 (en) * 1979-08-10 1985-03-13 Beecham Group Plc Beta-lactam antibiotics, their preparation, pharmaceutical compositions containing them and their preparation
EP0044142A1 (en) * 1980-07-03 1982-01-20 Beecham Group Plc Process for the preparation of beta-lactam antibiotics
EP0057565A1 (en) * 1981-02-04 1982-08-11 Beecham Group Plc Beta-lactam antibiotics, their preparation and use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH633554A5 (en) * 1975-11-21 1982-12-15 Merck & Co Inc Process for the preparation of novel thienamycin derivatives.

Also Published As

Publication number Publication date
CH639664A5 (en) 1983-11-30
FI772432A (en) 1978-02-18
IE45559B1 (en) 1982-09-22
AT351678B (en) 1979-08-10
BE857781A (en) 1978-02-13
CA1104139A (en) 1981-06-30
ZA774703B (en) 1978-06-28
SE7709071A0 (en) 1978-02-17
FR2405260A1 (en) 1979-05-04
IL52638A (en) 1980-12-31
DE2736482A1 (en) 1978-02-23
DK364177A (en) 1978-02-18
PT66882A (en) 1977-09-01
AU518375B2 (en) 1981-10-01
ATA592177A (en) 1979-01-15
SE7709071L (en) 1978-02-17
NZ184808A (en) 1980-04-28
FR2362142B1 (en) 1981-11-06
IE45559L (en) 1978-02-17
NL7709007A (en) 1978-02-21
JPS5323995A (en) 1978-03-06
IL52638A0 (en) 1977-10-31
FR2362142A1 (en) 1978-03-17
PT66882B (en) 1979-01-24
AU2798677A (en) 1979-02-22
FR2405260B1 (en) 1980-10-31
GB1531141A (en) 1978-11-01

Similar Documents

Publication Publication Date Title
IE781140L (en) Penicillanic acid s-oxides
IE32888L (en) Ó-amino-cyclohexadienylalkylene penicillins and¹cephalosporins
ES408972A1 (en) Acylimine cephalosporins
IE782546L (en) Amino-thiazolyl cephalosporins
IE39549B1 (en) Ureido-aryl cephalosporin compounds
ES461691A1 (en) Beta-lactam antibiotics
ES8104307A1 (en) 3-[(8-Carboxy-6-tetrazolo[1,5-b]pyridazinyl)-thiomethyl]-7-[2-(2-amino-4-thiazolyl)-2-methoxyimino-acetamido]-3-cephem-4-carboxylic acid
FR2191556A5 (en) N-Acylampicillins - with broad-spectrum antibacterial activity prepd. by acylation with naphthyridine carboxylic acids
ES462012A1 (en) 7-Substituted aminoacetamido oxadethiacephalosporins
GB1377661A (en) Oxofuryl ester derivatives of penicillin and cephalosporin
IE43681L (en) Penicillin compounds
GB1284227A (en) Penicillin and cephalosporin derivatives
IE38615L (en) Penicillin compounds
ES464008A1 (en) Monocyclic beta-lactams with antibacterial activity
ES438853A1 (en) Cephalosporin esters with antibacterial activity
ES8200371A1 (en) N-substituted thiazolyl derivatives of oxy-imino-substituted cephalosporins useful as anti-bacterial agents
ES8501405A1 (en) Chemical compound
ES8307251A1 (en) Derivatives of clavulanic acid, their preparation and their use.
ES476259A1 (en) Penicillanic acid derivatives, processes for their preparation and pharmaceutical compositions containing them.
GB1452692A (en) Amino substituted acylthio cephalosporins
ES409592A1 (en) Method for the preparation of cephalosporin derivatives
JPS56127381A (en) Beta-lactam compound and its preparation
IE45686L (en) 7-acylamino - 3 - (sulfomethylheterocyclic - thiomethyl)- 3¹- cephem -4- carboxylic acids.
ES436170A1 (en) Cephalosporin antibiotics
ES477209A1 (en) Preparation of the pivaloyloxymethyl ester of Cephalexin

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980202